Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Clinical trial NCT00142428 · COMPLETED

Trial details

NCT number: NCT00142428
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2005-01-01
Primary completion: 2005-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.